Policy of Developing and Selling Functional Materials as a Core Business
First written in FY2016-Q3. 18 of 25 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「In Japan and overseas, we are also pursuing the planning and sale of own-brand products (NB), etc., and OEM operations, leveraging the evidence accumulated through the development of functional ingredients.」
The description of the BtoB business has expanded from research, development and sales of functional ingredients to include own-brand products, OEM operations, and planning and sales in Japan and overseas. - FY2024RestatedAnnual report
「The BtoB business conducts research and development and manufacturing of functional ingredients, health foods, pharmaceuticals and other products, and sells them to food and pharmaceutical manufacturers, distributors and other customers.」
The Company continues to position its BtoB business as being based on functional ingredients and encompassing the research and development and manufacturing of health foods and pharmaceuticals and sales to manufacturers and distributors. - FY2024-Q1RestatedAnnual report
「The BtoB business conducts research and development and manufacturing of functional ingredients, health foods, pharmaceuticals and other products, and sells them to food and pharmaceutical manufacturers, distributors and other customers.」
The Company continues to describe its BtoB business as being based on functional ingredients and encompassing the research and development and manufacturing of health foods and pharmaceuticals and sales to manufacturers and distributors. - FY2023RestatedAnnual report
「This business is operated by the Company and Meiji Pharmaceutical Co., Ltd. It conducts research and development and manufacturing of functional ingredients, health foods, pharmaceuticals and other products, and sells them to food and pharmaceutical manufacturers, distributors and other customers.」
The Company continues its policy of operating a BtoB business based on functional ingredients that conducts research and development and manufacturing of health foods and pharmaceuticals and sells them to manufacturers and distributors. - FY2023-Q2AdvancedAnnual report
「As a result, BtoB business revenue for the six months ended in the second quarter of the current consolidated fiscal year was ¥4,071 million, up 11.6% year on year, and segment profit was ¥700 million, up 29.5% year on year.」
The BtoB business generated revenue of ¥4,071 million and segment profit of ¥700 million, resulting in higher revenue and profit year on year. - FY2022AdvancedAnnual report
「The BtoB business conducts research and development and manufacturing of functional ingredients, health foods, pharmaceuticals and other products, and sells them to food and pharmaceutical manufacturers, distributors and other customers.」
Following the consolidation of Meiji Pharmaceutical, the business has become established as a BtoB business encompassing the research and development and manufacturing of health foods and pharmaceuticals and sales to manufacturers and distributors, rather than the former description centered on functional ingredients. - FY2022-Q3ReframedAnnual report
「The BtoB business conducts research and development and manufacturing of functional ingredients, health foods, pharmaceuticals and other products, and sells them to food and pharmaceutical manufacturers, distributors and other customers.」
Following the consolidation of Meiji Pharmaceutical, the description of the business has expanded from one centered on functional ingredients to a BtoB business encompassing the research and development and manufacturing of health foods and pharmaceuticals and sales to manufacturers and distributors. - FY2022-Q1RestatedAnnual report
「The Functional Ingredients business researches and develops proprietary functional food ingredients and sells them to food manufacturers and others.」
This reaffirms the policy of operating a core business that researches and develops proprietary functional food ingredients and sells them to food manufacturers and others. - FY2021-Q1RestatedAnnual report
「The Functional Ingredients business researches and develops proprietary functional food ingredients and sells them to food manufacturers and others.」
The Company continues its policy of operating a core business that researches and develops proprietary functional food ingredients and sells them to food manufacturers and others. - FY2020-Q3RestatedAnnual report
「The Functional Ingredients business researches and develops proprietary functional food ingredients and sells them to food manufacturers and others.」
This reaffirms the policy of operating a core business that researches and develops proprietary functional food ingredients and sells them to food manufacturers and others. - FY2020-Q2RestatedAnnual report
「The Functional Ingredients business develops and sells proprietary functional ingredients.」
The Company continues its policy of operating a core business that develops and sells proprietary functional ingredients. - FY2020-Q1RestatedAnnual report
「The Functional Ingredients business sells proprietary functional ingredients, primarily for use in food products.」
The Company continues its policy of operating a core business that sells proprietary functional ingredients, primarily for use in food products. - FY2019-Q3RestatedAnnual report
「The Company achieved higher revenue and higher profit as sales of its flagship product, GABA, performed steadily.」
The Company continues to operate the Functional Ingredients business as a core business and sell its flagship ingredient, GABA. - FY2019-Q2RestatedAnnual report
「The market for Foods with Function Claims and health foods, to which the Functional Ingredients business belongs, is expanding against a backdrop of strong awareness of maintaining and improving health.」
The Company continues to develop the Functional Ingredients business as one of its main businesses. - FY2019-Q1RestatedAnnual report
「Both the Functional Ingredients business and the Direct-to-Consumer Sales business have performed strongly.」
The Company continues to position the Functional Ingredients business as one of its earnings bases and as a business that, together with the Direct-to-Consumer Sales business, drives growth. - FY2018-Q3RestatedAnnual report
「In Japan, sales have remained firm as notifications and sales of Foods with Function Claims using GABA have increased since the system was introduced last April. Bonepep has been expanded through powder drinks and yogurt products under Rohto Pharmaceutical Co., Ltd.’s and OHAYO DAIRY PRODUCTS CO., LTD.’s respective “SENOBIC” brands, as well as through sales to other domestic manufacturers.」
The Company continues to develop and sell functional ingredients such as GABA and Bonepep and to expand products containing those ingredients. - FY2018-Q2RestatedAnnual report
「In Japan, sales have remained firm as notifications and sales of Foods with Function Claims using GABA have increased since the system was introduced last April. Bonepep has been expanded through powder drinks and yogurt products under Rohto Pharmaceutical Co., Ltd.’s and OHAYO DAIRY PRODUCTS CO., LTD.’s respective “SENOBIC” brands, as well as through sales to other domestic manufacturers.」
The Company continues to develop and sell functional ingredients such as GABA and Bonepep, centered on functional ingredients, and to expand products containing those ingredients. - FY2018-Q1RestatedAnnual report
「The Functional Ingredients business develops and sells the Group’s core functional ingredients and plans and sells OEM (original equipment manufacturer) products containing those functional ingredients.」
The Company continues its policy of making the development and sale of functional ingredients, and the planning and sale of OEM products containing those ingredients, a core business. - FY2017-Q3RestatedAnnual report
「The Functional Ingredients business develops and sells the Group’s core functional ingredients and plans and sells OEM (original equipment manufacturer) products containing those functional ingredients.」
The Company continues its policy of making the development and sale of functional ingredients, and the planning and sale of OEM products containing those ingredients, a core business. - FY2017-Q2RestatedAnnual report
「The Functional Ingredients business develops and sells the Group’s core functional ingredients and plans and sells OEM (original equipment manufacturer) products containing those functional ingredients.」
The Company continues its policy of making the development and sale of functional ingredients, and the planning and sale of OEM products containing those ingredients, a core business. - FY2017-Q1RestatedAnnual report
「The Functional Ingredients business develops and sells the Group’s core functional ingredients and plans and sells OEM (original equipment manufacturer) products containing those functional ingredients.」
This reaffirms the policy of making the development and sale of functional ingredients, and the planning and sale of OEM products containing those ingredients, a core business. - FY2016-Q3First statedAnnual report
「The Functional Ingredients business develops and sells the Group’s core functional ingredients and plans and sells OEM (original equipment manufacturer) products containing those functional ingredients.」
The Company positions functional ingredients as a core business and develops both the ingredients themselves and OEM products containing them.